{"id":283450,"date":"2023-02-08T17:30:24","date_gmt":"2023-02-08T12:00:24","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=283450"},"modified":"2023-02-08T17:36:23","modified_gmt":"2023-02-08T12:06:23","slug":"khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/","title":{"rendered":"Khaitan & Co. advises Eris Group on its acquisition of a part of the dermatology portfolio of Glenmark Pharmaceuticals Limited"},"content":{"rendered":"
\n\n\n\n<\/colgroup>\n\n\n
\n

DEAL DETAILS<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<\/colgroup>\n\n\n\n\n
\n

Eris Lifesciences Limited | Brand agreement and supply of agreement between Eris Lifesciences Limited and Glenmark Pharmaceuticals Limited<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\n<\/td>\n<\/tr>\n

\n

\n<\/td>\n

\n

\n<\/td>\n

\n

\n<\/td>\n

\n

\n<\/td>\n

\n

\n<\/td>\n

\n

\n<\/td>\n

\n

\n<\/td>\n

\n

\n<\/td>\n<\/tr>\n

\n

\n<\/td>\n

\n\n\n\n\n\n<\/colgroup>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

NO<\/p>\n<\/td>\n

\n

HEADINGS<\/p>\n<\/td>\n

\n

DETAILS<\/p>\n<\/td>\n<\/tr>\n

\n

1.<\/p>\n<\/td>\n

\n

Sector<\/p>\n<\/td>\n

\n

Pharmaceutical Industry<\/p>\n<\/td>\n<\/tr>\n

\n

2.<\/p>\n<\/td>\n

\n

Announcement Date<\/p>\n<\/td>\n

\n

17-Jan-2023<\/p>\n<\/td>\n<\/tr>\n

\n

3.<\/p>\n<\/td>\n

\n

Completion Date<\/p>\n<\/td>\n

\n

17-Jan-2023<\/p>\n<\/td>\n<\/tr>\n

\n

4.<\/p>\n<\/td>\n

\n

Name of Client<\/p>\n<\/td>\n

\n

Eris Lifesciences Limited<\/p>\n

Eris Lifesciences Ltd is a publicly listed Indian pharmaceutical company with a pure-play domestic branded formulations business model. Eris has established a leading presence in its core cardio-metabolic franchise in just 15 years from inception. Eris is also successfully diversifying its business with 3 emerging therapies (Dermatology, Neuropsychiatry and Gynaecology).<\/p>\n<\/td>\n<\/tr>\n

\n

5.<\/p>\n<\/td>\n

\n

Buyer Details<\/p>\n<\/td>\n

\n

Eris Oaknet Healthcare Private Limited | India<\/p>\n<\/td>\n<\/tr>\n

\n

6.<\/p>\n<\/td>\n

\n

Seller Details<\/p>\n<\/td>\n

\n

Glenmark Pharmaceuticals Limited | India<\/p>\n<\/td>\n<\/tr>\n

\n

7.<\/p>\n<\/td>\n

\n

Deal Description<\/p>\n<\/td>\n

\n

Eris Oaknet Healthcare Private Limited (a wholly owned subsidiary of the listed entity, Eris Lifesciences Limited) acquired a part of the dermatology portfolio of Glenmark Pharmaceuticals Limited by way of acquisition of 9 (Nine) trademarks along with their applicable line extensions. Eris Oaknet Healthcare Private Limited is the entity which focuses on the dermatology segment business of the listed entity. This transaction helps augment and expand the business of Eris Oaknet Healthcare Private Limited by way of expansion in product offerings<\/p>\n<\/td>\n<\/tr>\n

\n

8.<\/p>\n<\/td>\n

\n

Total Consideration<\/p>\n<\/td>\n

\n

INR 340 crore (USD 42 million)<\/p>\n<\/td>\n<\/tr>\n

\n

9.<\/p>\n<\/td>\n

\n

Team Members<\/p>\n<\/td>\n

\n

The core team consisted of Kalpana Unadkat (Partner), Aman Anand (Senior Associate), Ahaan Dar (Associate) with assistance from the following:Arindam Ghosh (Partner), Shailendra Bhandare (Partner)<\/p>\n<\/td>\n<\/tr>\n

\n

10.<\/p>\n<\/td>\n

\n

Role of Firm<\/p>\n<\/td>\n

\n

Khaitan & Co. advised Eris Group on its acquisition of a part of the dermatology portfolio of Glenmark Pharmaceuticals Limited by way of acquisition of 9 (Nine) trademarks along with their applicable line extensions.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\n<\/td>\n<\/tr>\n

\n

\n<\/td>\n

\n

\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

DEAL DETAILS Eris Lifesciences Limited | Brand agreement and supply of agreement between Eris Lifesciences Limited and Glenmark Pharmaceuticals Limited NO HEADINGS <\/p>\n","protected":false},"author":8808,"featured_media":283457,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[45282,2],"tags":[53672,50442,55079,55081,55080,6791,54243],"class_list":["post-283450","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-deal-description","tag-deal-details","tag-dermatology-portfolio","tag-eris-group","tag-glenmark-pharmaceuticals-limited","tag-khaitan-co","tag-seller-details"],"yoast_head":"\nKhaitan & Co. advises Eris Group on its acquisition of a part of the dermatology portfolio of Glenmark Pharmaceuticals Limited | SCC Times<\/title>\n<meta name=\"description\" content=\"Eris Lifesciences Limited | Brand agreement and supply of agreement between Eris Lifesciences Limited and Glenma\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Khaitan & Co. advises Eris Group on its acquisition of a part of the dermatology portfolio of Glenmark Pharmaceuticals Limited\" \/>\n<meta property=\"og:description\" content=\"Eris Lifesciences Limited | Brand agreement and supply of agreement between Eris Lifesciences Limited and Glenma\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-08T12:00:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-08T12:06:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/02\/MicrosoftTeams-image-339.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"390\" \/>\n\t<meta property=\"og:image:height\" content=\"310\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Bhumika Indulia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bhumika Indulia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/\",\"name\":\"Khaitan & Co. advises Eris Group on its acquisition of a part of the dermatology portfolio of Glenmark Pharmaceuticals Limited | SCC Times\",\"isPartOf\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/02\/MicrosoftTeams-image-339.jpg\",\"datePublished\":\"2023-02-08T12:00:24+00:00\",\"dateModified\":\"2023-02-08T12:06:23+00:00\",\"author\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/919ec47cc1b871b362af05740398033a\"},\"description\":\"Eris Lifesciences Limited | Brand agreement and supply of agreement between Eris Lifesciences Limited and Glenma\",\"breadcrumb\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/#primaryimage\",\"url\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/02\/MicrosoftTeams-image-339.jpg\",\"contentUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/02\/MicrosoftTeams-image-339.jpg\",\"width\":390,\"height\":310},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.scconline.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Khaitan & Co. advises Eris Group on its acquisition of a part of the dermatology portfolio of Glenmark Pharmaceuticals Limited\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\",\"url\":\"https:\/\/www.scconline.com\/blog\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.scconline.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/919ec47cc1b871b362af05740398033a\",\"name\":\"Bhumika Indulia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/04\/Me-150x150.jpg\",\"contentUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/04\/Me-150x150.jpg\",\"caption\":\"Bhumika Indulia\"},\"url\":\"https:\/\/www.scconline.com\/blog\/post\/author\/editor_1\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Khaitan & Co. advises Eris Group on its acquisition of a part of the dermatology portfolio of Glenmark Pharmaceuticals Limited | SCC Times","description":"Eris Lifesciences Limited | Brand agreement and supply of agreement between Eris Lifesciences Limited and Glenma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/","og_locale":"en_US","og_type":"article","og_title":"Khaitan & Co. advises Eris Group on its acquisition of a part of the dermatology portfolio of Glenmark Pharmaceuticals Limited","og_description":"Eris Lifesciences Limited | Brand agreement and supply of agreement between Eris Lifesciences Limited and Glenma","og_url":"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2023-02-08T12:00:24+00:00","article_modified_time":"2023-02-08T12:06:23+00:00","og_image":[{"width":390,"height":310,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/02\/MicrosoftTeams-image-339.jpg","type":"image\/jpeg"}],"author":"Bhumika Indulia","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Bhumika Indulia","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/","url":"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/","name":"Khaitan & Co. advises Eris Group on its acquisition of a part of the dermatology portfolio of Glenmark Pharmaceuticals Limited | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/02\/MicrosoftTeams-image-339.jpg","datePublished":"2023-02-08T12:00:24+00:00","dateModified":"2023-02-08T12:06:23+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/919ec47cc1b871b362af05740398033a"},"description":"Eris Lifesciences Limited | Brand agreement and supply of agreement between Eris Lifesciences Limited and Glenma","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/02\/MicrosoftTeams-image-339.jpg","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/02\/MicrosoftTeams-image-339.jpg","width":390,"height":310},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Khaitan & Co. advises Eris Group on its acquisition of a part of the dermatology portfolio of Glenmark Pharmaceuticals Limited"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/919ec47cc1b871b362af05740398033a","name":"Bhumika Indulia","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/04\/Me-150x150.jpg","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/04\/Me-150x150.jpg","caption":"Bhumika Indulia"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_1\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/02\/MicrosoftTeams-image-339.jpg","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":287398,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/03\/21\/khaitan-co-advises-eris-lifesciences-limited-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-dr-reddys-laboratories-limited\/","url_meta":{"origin":283450,"position":0},"title":"Khaitan & Co advises Eris Lifesciences Limited on its acquisition of a part of the dermatology portfolio of Dr. Reddy’s Laboratories Limited","author":"Bhumika Indulia","date":"March 21, 2023","format":false,"excerpt":"Khaitan & Co has advised Eris Lifesciences Limited on its acquisition of a part of the dermatology portfolio of Dr. Reddy's Laboratories Limited for a total consideration of INR 275 crores. The acquisition helps augment and expand the dermatology business of Eris Lifesciences in India. The team assisted in drafting,\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/03\/MicrosoftTeams-image-811.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/03\/MicrosoftTeams-image-811.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/03\/MicrosoftTeams-image-811.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/03\/MicrosoftTeams-image-811.png?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":317745,"url":"https:\/\/www.scconline.com\/blog\/post\/2024\/03\/19\/khaitan-co-advises-eris-lifesciences-limited-on-its-acquisition-of-the-branded-formulations-business-of-biocon-biologics-limited-in-india\/","url_meta":{"origin":283450,"position":1},"title":"Khaitan & Co advises Eris Lifesciences Limited on its acquisition of the branded formulations business of Biocon Biologics Limited in India","author":"Bhumika Indulia","date":"March 19, 2024","format":false,"excerpt":"DEAL DETAILS Eris Lifesciences Limited | Acquisition of the Indian branded formulations business of Biocon Biologics Limited Khaitan & Co advised Eris Lifesciences Limited on its acquisition of the branded formulations business of Biocon Biologics Limited in India for a total consideration of INR 1,242 Crores. The acquisition helps augment\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Eris Lifesciences Limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/03\/biocon.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/03\/biocon.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/03\/biocon.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/03\/biocon.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":264932,"url":"https:\/\/www.scconline.com\/blog\/post\/2022\/04\/02\/khaitan-co-advised-alembic-in-relation-to-acquisition-of-balance-40-stake-in-aleor\/","url_meta":{"origin":283450,"position":2},"title":"Khaitan & Co advised Alembic in relation to acquisition of balance 40% stake in Aleor","author":"Bhumika Indulia","date":"April 2, 2022","format":false,"excerpt":"Khaitan & Co advised Alembic in relation to acquisition of balance 40% stake in Aleor, a joint venture company of Alembic and Orbicular Pharmaceutical Technologies Private Limited, thereby making Aleor a wholly owned subsidiary of Alembic. NO HEADINGS \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DETAILS 1. Sector Pharmaceuticals - Dermaceuticals 2. Announcement Date 29 March\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/04\/MicrosoftTeams-image-131.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/04\/MicrosoftTeams-image-131.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/04\/MicrosoftTeams-image-131.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/04\/MicrosoftTeams-image-131.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/04\/MicrosoftTeams-image-131.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":308625,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/12\/07\/sam-advises-eris-lifesciences-limited-acquisition-of-dermatology-and-nephrology-branded-formulations-business-units\/","url_meta":{"origin":283450,"position":3},"title":"SAM advises Eris Lifesciences Limited on its acquisition of Dermatology and Nephrology branded formulations business units of Biocon Biologics Limited in India","author":"Bhumika Indulia","date":"December 7, 2023","format":false,"excerpt":"Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (\u201cEris\u201d) on its acquisition of Dermatology and Nephrology branded formulations business units of Biocon Biologics Limited (\u201cBiocon\u201d) in India. The deal is valued at approximately INR 366 crores and the date of closing the deal was 10 November 2023. This acquisition marks the\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Eris Lifesciences Limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":289762,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/04\/15\/khaitan-co-advises-connell-caldic-on-the-acquisition-of-business-undertakings-of-chemhouse-marketing-india-and-brink-chemicals-india\/","url_meta":{"origin":283450,"position":4},"title":"Khaitan & Co advises Connell Caldic on the acquisition of business undertakings of Chemhouse Marketing, India and Brink Chemicals, India.","author":"Bhumika Indulia","date":"April 15, 2023","format":false,"excerpt":"DEAL DETAILS Connell Caldic | Acquisition of business undertakings of Chemhouse Marketing and Brink Chemicals Khaitan & Co advised Connell Caldic on the acquisition of business undertakings of Chemhouse Marketing, India and Brink Chemicals, India (Targets). The Targets are India-based distributor of value-added solutions to the personal care and topical\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"chemhouse marketing","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/04\/chemhouse-marketing.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/04\/chemhouse-marketing.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/04\/chemhouse-marketing.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/04\/chemhouse-marketing.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":18422,"url":"https:\/\/www.scconline.com\/blog\/post\/2015\/10\/08\/glenmark-restrained-from-manufacturing-and-selling-its-anti-diabetes-drugs\/","url_meta":{"origin":283450,"position":5},"title":"Glenmark restrained from manufacturing and selling its anti-diabetes drugs","author":"Sucheta","date":"October 8, 2015","format":false,"excerpt":"Delhi High Court: In granting permanent injunction to US drug company Merck Sharp and Dohme (MSD), the Court restrained Indian firm Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs \"Zita\" and \"Zita-Met\", saying it has infringed patent of the plaintiff. The US drug maker in its plea had sought\u2026","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/283450","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/8808"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=283450"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/283450\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/283457"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=283450"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=283450"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=283450"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}